alexa Therapeutic And Immunomodulatory Potential Of Brugia Malayi Cystatin In Inflammatory And Autoimmune Disorders | 68555
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Conference on Parasitology & Pathogenesis

Vishal Khatri, Nitin Amdare, MVR Reddy and Ramaswamy Kalyanasundaram
University of Illinois, USA
Albert Einstein College of Medicine, New York, USA
Mahatma Gandhi Institute of Medical Sciences, India
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597-C1-031
Abstract
The concept of hygiene hypothesis has directed us to investigate anti-inflammatory and therapeutic potential of Brugia malayi recombinant cystatin (rBmCys) in immune-mediated disorders such as, ulcerative colitis (UC) and Type-1 diabetes (T1D) in rodent models. The anti-inflammatory activity of rBmCys on mice peritoneal exudate cells was initially checked in vitro. Colitis was induced by administering Dextran Sulfate Sodium (DSS) orally on days 3, 4 and 5. Different groups of colitis-induced mice were treated with rBmCys (10/25/50 μg/dose/i.p). Treatment with rBmCys reversed the pathology in DSS-induced colitis, these include no weight loss, absence of any occult blood in the feces and absence of pathological changes in the colon. The amelioration of the symptoms and pathology in the DSS-colitis model after rBmCys treatment was dose dependent. For T1D, streptozotocin-induced diabetic mice were used and four doses of rBmCys (25μg/dose/i.p.) were given at 15 days intervals after the onset of the disease. All the treated animals were assessed for changes in the clinical parameters, humoral and cellular immune responses. Treatment with rBmCys ameliorated the overall disease severity of T1D. Fasting blood glucose levels were decreased to 37% following treatment with rBmCys. Histopathological analysis showed that >44% of the total pancreatic islets were protected from inflammatory changes and cell death. This improvement in colitis and T1D correlated with a generalized shift towards Th2 type of immune response in rBmCys treated animals. The findings from this study show that rBmCys is a promising immunomodulatory molecule for reversing the symptoms of colitis and T1D.
Biography

Vishal Khatri, completed his PhD and working as an research associate at Department of Biomedical Sciences, College of Medicine Rockford, University of Illinois, Rockford, Department of Microbiology & Immunology under the super vision of Dr. Ramaswamy Kalyanasundaram, Professor & Head of Department.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7